Table 4

Differences in muscle strength between sides according to disease severity as assessed with the CMT Neuropathy Score (CMTNS)

 CMTNSNMean±SDp Value for Δ*
DNDΔ
FDIMild554.15±0.404.18±0.43−0.04±0.330.634
Moderate1873.80±0.723.82±0.82−0.02±0.39
Severe252.24±1.202.20±1.220.04±0.35
APBMild554.22±0.764.31±0.77−0.09±0.400.202
Moderate1873.83±0.893.84±0.87−0.01±0.37
Severe262.77±1.272.77±1.420.00±0.57
ATMild554.45±0.694.36±0.590.09±0.400.192
Moderate1873.32±1.273.31±1.320.01±0.64
Severe251.76±1.331.68±1.380.08±0.49
TSMild554.98±0.134.98±0.130.00±0.000.011
Moderate1864.64±0.854.62±0.910.02±0.27
Severe253.28±1.813.12±1.720.16±0.37
  • Bold value indicates significant difference.

  • Average difference (Δ=D−ND) of strength between DH and NDH according disease severity (as assessed by CMTNS) is shown. Three subgroups were considered: mild (0–10); moderate (11–20); severe (21–36).

  • *Between CMTNS levels overall comparison by Kruskal–Wallis test.

  • APB, abductor pollicis brevis; AT, anterior tibialis; CMT, Charcot–Marie–Tooth; D, dominant side; DH, dominant hand; FDI, first dorsal interosseous; N, number of tested patients; ND, non-dominant side; NDH, non-dominant hand; TS, triceps surae.